RECENT DEVELOPMENTS IN THE DETECTION AND CLASSIFICATION OF LEUKEMIA - A COMPREHENSIVE EVALUATION OF DEEP LEARNING SOLUTIONS
Main Article Content
Abstract
The blood is essential for keeping us alive since it carries oxygen, nutrients, and immune cells around the body. Leukemia is a type of cancer that affects the tissues that make blood. It can be deadly if not caught early. So, finding it early is for getting the right therapy and living longer. Blood smear analysis using a microscope has long been a major way to diagnose diseases. However, looking at these pictures by hand takes a lot of time, is easy to make mistakes, and isn't always consistent. Machine learning (ML) and other automated methods have been used to solve these problems by looking at enormous datasets and finding patterns that are difficult to see by hand. But ML methods frequently need people to choose the right features, and they might not work well with data that is complicated and has a lot of dimensions. Deep learning (DL) solves these problems by automatically learning important aspects from raw medical images. This makes it easier and faster to find leukemia. DL models, notably convolutional neural networks (CNNs), have shown that they can classify different types of leukemia better than other methods with little help from people. This article gives a full picture of the most recent improvements in DL methods for finding leukemia and shows how they could change the way blood tests are done. Also, a comparison of several DL models is shown, along with their pros and cons, to that they can still provide more accurate diagnoses and lower the chance of human error. There is also a discussion of the problems and opportunities in this sector, with a focus on how DL can help find leukemia early and accurately.
Downloads
Article Details
COPYRIGHT
Submission of a manuscript implies: that the work described has not been published before, that it is not under consideration for publication elsewhere; that if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
- The journal allows the author(s) to retain publishing rights without restrictions.
- The journal allows the author(s) to hold the copyright without restrictions.